Dana-Farber Brigham Cancer Center provides specialized treatment and care for adult lymphoma including Hodgkin lymphoma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia (CLL).
Dana-Farber Brigham Cancer Center's Lymphoma Program has extensive experience caring for patients with lymphoid malignancies, including Hodgkin lymphoma, non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), B-cell neoplasms, and T-cell neoplasms. Our focused expertise is important because lymphoma encompasses more than 70 tumor types, each requiring a different treatment approach.
We see more than 1,000 new patients each year—the kind of high-volume experience that studies show improves health outcomes. In addition, we offer patients access to clinical trials of promising new lymphoma treatments, such as CAR T-cell therapy, a new form of immunotherapy. Right now you have cancer. But what your cancer doesn't know is, you have us.
Our multidisciplinary team will carefully review your medical history and will create an individualized treatment plan based on your specific diagnosis. We provide comprehensive services to patients with lymphoma, including: